{"id":"https://openalex.org/W21675321","doi":"https://doi.org/10.2165/00023210-199810050-00004","title":"Serotonin 5-HT1A Receptor Agonists as Antidepressants: Pharmacological Rationale and Evidence for Efficacy","display_name":"Serotonin 5-HT1A Receptor Agonists as Antidepressants: Pharmacological Rationale and Evidence for Efficacy","alternate_titles":[],"publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W21675321","doi":"https://doi.org/10.2165/00023210-199810050-00004","mag":"21675321"},"language":"en","primary_location":{"id":"doi:10.2165/00023210-199810050-00004","doi":"https://doi.org/10.2165/00023210-199810050-00004","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00023210-199810050-00004","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W21675321"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075729417","display_name":"Jon F. Heiser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110209","display_name":"Pharmacology Research Institute","ror":"https://ror.org/01zwbyz86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210110209"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jon F. Heiser","raw_affiliation_strings":["Pharmacology Research Institute, 1000 Dove Street, Suite 200, Newport Beach, California, 92660-2814, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Research Institute, 1000 Dove Street, Suite 200, Newport Beach, California, 92660-2814, USA","institution_ids":["https://openalex.org/I4210110209"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085611730","display_name":"Charles S. Wilcox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110209","display_name":"Pharmacology Research Institute","ror":"https://ror.org/01zwbyz86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210110209"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles S. Wilcox","raw_affiliation_strings":["Pharmacology Research Institute, 1000 Dove Street, Suite 200, Newport Beach, California, 92660-2814, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Research Institute, 1000 Dove Street, Suite 200, Newport Beach, California, 92660-2814, USA","institution_ids":["https://openalex.org/I4210110209"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075729417"],"corresponding_institution_ids":["https://openalex.org/I4210110209"],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":null,"fwci":0.8586,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.73785273,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"10","issue":"5","first_page":"343","last_page":"353"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.8859999775886536},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.9509999752044678},{"id":"https://openalex.org/keywords/azapirones","display_name":"azapirones","score":0.8199999928474426},{"id":"https://openalex.org/keywords/gepirone","display_name":"gepirone","score":0.9139999747276306},{"id":"https://openalex.org/keywords/ipsapirone","display_name":"ipsapirone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tandospirone","display_name":"tandospirone","score":0.996999979019165},{"id":"https://openalex.org/keywords/flesinoxan","display_name":"flesinoxan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adjunctive-antidepressant-therapy","display_name":"adjunctive antidepressant therapy","score":0.7409999966621399},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6740000247955322},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7519999742507935},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.6700000166893005},{"id":"https://openalex.org/keywords/transdermal-administration","display_name":"transdermal administration","score":0.765999972820282},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.8951985836029053},{"id":"https://openalex.org/C2778362415","wikidata":"https://www.wikidata.org/wiki/Q6065448","display_name":"Ipsapirone","level":5,"score":0.7375831604003906},{"id":"https://openalex.org/C2781093953","wikidata":"https://www.wikidata.org/wiki/Q21115043","display_name":"5-HT1A receptor","level":5,"score":0.6337321996688843},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5520973205566406},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.525793731212616},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49471208453178406},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.486436128616333},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4833352267742157},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4464928209781647},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.43085744976997375},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.38869622349739075},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3441861867904663},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.3136065602302551},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.28494584560394287},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.2771511375904083},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2675015926361084},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15513333678245544}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2165/00023210-199810050-00004","doi":"https://doi.org/10.2165/00023210-199810050-00004","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00023210-199810050-00004","pdf_url":null,"source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W52990025","https://openalex.org/W107475310","https://openalex.org/W967356148","https://openalex.org/W1930767620","https://openalex.org/W1963643315","https://openalex.org/W2007300202","https://openalex.org/W2009159786","https://openalex.org/W2017826185","https://openalex.org/W2018764502","https://openalex.org/W2023835100","https://openalex.org/W2031478341","https://openalex.org/W2057346541","https://openalex.org/W2062092988","https://openalex.org/W2074305421","https://openalex.org/W2095450002","https://openalex.org/W2114613490","https://openalex.org/W2152620512","https://openalex.org/W2160070901","https://openalex.org/W2227468449","https://openalex.org/W2321617757","https://openalex.org/W2329944502","https://openalex.org/W2332543303","https://openalex.org/W2395231159","https://openalex.org/W2397631561","https://openalex.org/W2397662701","https://openalex.org/W2398765899","https://openalex.org/W2409775452","https://openalex.org/W2412752030","https://openalex.org/W2413312230","https://openalex.org/W2414971391","https://openalex.org/W2418529718","https://openalex.org/W2427020732","https://openalex.org/W2443710144","https://openalex.org/W2496235609","https://openalex.org/W3212023210","https://openalex.org/W3217134939"],"related_works":["https://openalex.org/W967356148","https://openalex.org/W1968912840","https://openalex.org/W2057346541","https://openalex.org/W1977536159","https://openalex.org/W2062158247","https://openalex.org/W2070500796","https://openalex.org/W2485056995","https://openalex.org/W936595910","https://openalex.org/W2130370820","https://openalex.org/W2781010046"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W21675321","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
